UNSPSC 51162313: Acetaminophen/chlorpheniramine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162313 Acetaminophen/chlorpheniramine/phenylpropanolamine is a Commodity code, but the recent state and local opportunities tagged under it reflect a broader pharmaceutical procurement pattern: parenteral products, intravenous solutions, and emergency medical supplies including naloxone rather than the specific combination-drug formulation the code nominally describes. State and local governments are using this code family to solicit pharmaceutical inventory for correctional healthcare, emergency medical response, and community health programs. The issuing bodies are state departments of corrections and county health authorities, reflecting the clinical and custodial contexts where these supplies are deployed.

Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026 (response due October 7, 2026) for parenteral products, services, and equipment to supply eight correctional facilities across Washington state. The scope includes parenteral nutrition solutions (TPN and PPN), intravenous solutions, and controlled substances for incarcerated individuals, with 24-hour delivery requirements for PN bags and 8-hour delivery for other products; DOC anticipates awarding up to three contractors per region across West, Central, and East zones. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Washington procurement carries set-aside goals including 25% small business, 10% minority-owned, 6% women-owned, and 5% veteran-owned participation. Both contracts span two to three years with renewal or extension options and require insurance coverage, business licensure, and background clearance compliance.